Neurocrine Biosciences, Inc. today announced the initiation of its Phase 2 clinical study to assess the safety and tolerability of crinecerfont in children aged 3 months to under 4 years with classic ...
Well folks, July is here and there is good and bad. The bad is the temperature and humidity. Be sure to cool off whenever available and drink plenty of water.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results